European Trial of Immunosuppression in SPK Tx

NCT00140543 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

228

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 1
Diabetic Nephropathy

Interventions

DRUG: sirolimus versus mycophenolate mofetil

Sponsor

EUROSPK Study Group

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]